BioCorRx (BICX) Invested Capital (2010 - 2026)

BioCorRx has disclosed Invested Capital across 17 years of filings, most recently posting -$6.7 million for Q1 2026.

• Invested Capital for Q1 2026 came in at -$6.7 million, up 43.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.7 million (up 43.0% YoY), and the FY2025 annual result was -$6.4 million, up 19.98% from the prior year.
• Invested Capital came in at -$6.7 million for Q1 2026 at BioCorRx, down from -$6.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.1 million in Q3 2025 to a low of -$11.8 million in Q1 2025.
• The 5-year median for Invested Capital is -$6.8 million (2024), against an average of -$6.5 million.
• Across the five-year window, Invested Capital slumped 284.58% in 2022 and surged 113.69% in 2025, its largest moves.
• BioCorRx's Invested Capital stood at -$4.9 million in 2022, then declined by 26.22% to -$6.1 million in 2023, then sank by 31.36% to -$8.1 million in 2024, then rose by 19.98% to -$6.4 million in 2025, then slipped by 4.41% to -$6.7 million in 2026.
• The last three Invested Capital figures came in at -$6.7 million (Q1 2026), -$6.4 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.